Cours Eidos Therapeutics, Inc.
Actions
EIDX
US28249H1041
Recherche biotechnologique et médicale
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Neil Kumar
CEO | Chief Executive Officer | 45 | 01/03/16 |
Jonathan Fox
PSD | President | 67 | 01/10/16 |
Uma Sinha
CTO | Chief Tech/Sci/R&D Officer | 67 | 01/06/16 |
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Uma Sinha
CTO | Chief Tech/Sci/R&D Officer | 67 | 01/06/16 |
Jonathan A. Barr
BRD | Director/Board Member | - | 26/01/21 |
Jonathan Fox
PSD | President | 67 | 01/10/16 |
Varia. 1 janv. | Capi. | |
---|---|---|
-2,26 % | 104 Md | |
+1,41 % | 97,42 Md | |
+0,79 % | 22,2 Md | |
-17,84 % | 21,23 Md | |
-11,11 % | 18,33 Md | |
-42,83 % | 16,35 Md | |
-17,63 % | 15,06 Md | |
+4,55 % | 13,98 Md | |
+32,11 % | 11,66 Md |